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ABSTRACT
Asymptomatic infection appears to be a common cause offallopian tube damage resulting in ectopic
pregnancy or infertility. (C) 1993 Wiley-Liss, Inc.
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he role of serious pelvic infection in female
infertility is well recognized. However, the
role of asymptomatic infection caused by Neisseria
gonorrhoeae and Chlamydia trachomatis, although of
great concern, has not been well established. Sig-
nificant research efforts have been made to define
these asymptomatic sexually transmitted diseases
(STDs) and their role in infertility. In conjunction
with much of the theorizing on the infectious etiol-
ogy of infertility, the role of the vaginal microflora
has also been implicated in these infections. Cur-
rently, the initial infection is thought to be due to
the gonococcus and/or chlamydia. This initial in-
fection is then followed by ascension of potentially
destructive microbes endogenous to the lower fe-
male genital tract.
THE VAGINAL MICROFLORA
The lower female genital tract is a delicate ecosys-
tem maintained in dynamic equilibrium. This bal-
ance can be tipped by any number of factors, both
endogenous and exogenous. The bacteriologic
make-up of the lower genital tract includes both
synergistic bacteria and antagonistic organisms. The
healthy vaginal ecosystem is characterized by a pI--I
of 3.8 to 4.2; a slate-grey to white, odorless dis-
charge; and the presence of other gram-positive
commensal bacteria, with the dominant bacterium
being Lactobacillus. Also present are many other
bacteria, gram-positive aerobes, facultative gram-
negative bacteria, anaerobic gram-negative bac-
teria, and gram-positive bacteria. The presence of
Lactobacillus appears to be pivotal in maintaining
the equilibrium and preventing potentially patho-
genic bacteria from gaining dominance. The cur-
rent theory is that the production of lactic acid by
lactobacilli maintains the appropriate pH. In addi-
tion, these bacteria produce hydrogen peroxide that
is toxic to anaerobic bacteria, which do not produce
peroxidase. When the balance is upset, the com-
mensal bacteria decrease in number, reducing the
hydrogen ion concentration and hydrogen peroxide
and allowing the growth of facultative and anaero-
bic bacteria, thereby resulting in an unhealthy state.
Important to remember is that, despite the many
forms of vaginitis, certain types are more conduc-
tive to the production of" upper genital tract infec-
tion, such as endometritis and salpingitis. The most
common types of vaginitis are bacterial vaginitis
(30% to 35% of cases), yeast vaginitis (20%-25%),
and trichomoniasis (10%-15%).
2-4 Trichomonia-
sis should serve as a marker organism for the possi-
ble existence of other infections, as it is commonly
found in association with gonorrhea and chlamy-
dia.
5-7
The unhealthy or abnormal vaginal flora is char-
acterized by a pH >4.5. A discharge is also char-
acteristic; it is usually dirty-grey but may be colors
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other than white. It may or may not be frothy and
may or may not be homogenous. Typically, it emits
an amine odor when mixed with 10% potassium
hydroxide (KOH). Microscopic examination usu-
ally reveals the squamous epithelial cells to be cov-
ered by adherent bacteria, obliterating the cytoplas-
mic membrane and nucleus. In the case of bacterial
vaginosis (BV), white blood cells (WBCs) are usu-
ally absent, thus the use of the suffix "-osis" to
indicate the absence of an inflammatory reaction,
but numerous individually free-floating bacteria
are present.
Microbiologic evaluation of this type of lower
genital tract will reveal the presence of large num-
bers of facultative and obligate anaerobes. With
BV, the patient is more likely to have an STD. In
one study, 54% of the women with BV reported
having had an STD. Other bacterial derangements
of the vaginal microflora may exist, especially in
patients who have been repeatedly treated for
vaginitis but whose flora has not regained the com-
position of a healthy state. Gardnerella vaginalis
vaginitis, originally described by Gardner and
Dukes, consists of a vaginal discharge resembling
that of BV, but differing in that the free-floating
bacteria found in the vaginal fluid are not individ-
ually distributed but in aggregates. Rarely, if ever,
are WBCs present.
9 Some patients present with
bacterial vaginitis consisting predominantly of
Gardnerella vaginalis with few, if any, other types
of bacteria and, rarely, anaerobes. Whereas other
types of vaginitis may have clinical parameters sim-
ilar to those found with BV, 30% of patients with a
discharge that liberates a foul odor will have BV
and 17% of patients with clue cells but no dominant
anaerobic bacteria will have BV.
1 In one study,
patients with persistent vaginitis who had been re-
peatedly treated with antibiotics were enrolled.
1’
All patients had a vaginal pH of > 4.5 and the
liberation of amines when the discharge was mixed
with 10% KOI-I. These patients were divided into
two groups. The first group consisted of 48 pa-
tients. Microscopic analysis of the vaginal fluid of
all patients in the first group demonstrated numer-
ous individually free-floating bacteria and numer-
ous WBCs. Half of the patients in this first group
did not demonstrate Gardnerella vaginalis as part of
the microflora, and half demonstrated Gardnerella
vaginalis in counts of <103 colony-forming units
per ml (cfu/ml) of vaginal fluid. The second group
of patients all demonstrated Gardnerella vaginalis,
but in high colony counts of 3 l0 s to 9 10
9
cfu/ml of vaginal fluid. The vaginal fluid of the
patients in this second group revealed clue cells,
rare WBCs, and bacteria floating in clumps, not
individually. The finding of varieties of bacterial
infections raises the concern regarding not the par-
ticular type of vaginitis, but the possibility that the
bacteria present may ascend to the upper genital
tract and act synergistically in causing a progressive
infection.
Important to remember is that the individual
with bacterial vaginitis or BV is at greater risk for
having an accompanying STD. This epidemiologic
information is important for two reasons. First, it
implies that the patient’s behavior pattern may cur-
rently place her at risk for upper genital tract infec-
tion. Second, it encourages the physician to obtain a
detailed sexual history to determine if the patient
has been at risk for a prolonged time, making the
possibility of" a past or present upper genital tract
infection more of a reality.
EVALUATION OF THE PATIENT
FOR INFECTION
The physician should encounter little difficulty in
evaluating the patient with an acute symptomatic
genital tract infection. However, the goal should
be the prevention of damage of the fallopian tubes
which might result in abnormal function or infer-
tility. The annual ectopic pregnancy rate from 1970
through 1989 has risen four-fold from 4.5 to 16.1/
1000 pregnancies.
12 Hospital admissions for ec-
topic pregnancy in 1991 were 88,400, a 10% in-
crease over 1988. This rise in the ectopic pregnancy
rate is believed to be due to the rise in the number
of cases of pelvic inflammatory disease (PID). Al-
though obtaining data with regard to infertility and
infection is difficult, the estimation has been made
that, after a single episode of PID, approximately
12% of the women will be infertile; after two epi-
sodes, 25% will be infertile; and, after three or
more episodes, more than 50% will be infertile.
3
The Centers for Disease Control has estimated that
four million initial visits to physicians for PID
were made in 1991, generating approximately
250,000 hospital admissions.
14
To prevent fallopian tube damage, the physician
must recognize the earliest stage of the disease pro-
cess. The initial site of infection in the female pa-
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tient is the cervix. However, the difficulty lies in
the fact that the greatest percentage of infected
women are asymptomatic. The physician may be
clued in by asking the patient the appropriate ques-
tions indicating historical evidence for the possible
existence of an STD:
1. Have you noticed a change in your vaginal
discharge?
2. Do you have spotting following sexual inter-
course?
3. Have you noticed a sudden onset of pain with
sexual intercourse?
Close attention should be paid to the endocervi-
cal epithelium, specifically noting the presence of
hypertrophy. A dacron swab should be passed into
the endocervical canal and rotated for 5 to 10 sec-
onds to determine if any endocervical mucus is
present. Typical findings suggesting cervical infec-
tion, namely Chlamydia trachomatis and Neisseria
gonorrhoeae, are that (1) the endocervical tissue
bleeds easily when the pap smear is taken and (2)
the patient’s pap smear reveals inflammation.
15,16
The physician should remember that patients do
not present with complaints of cervicitis and that
cervical infectionbyN. gonorrhoeaeand/or C. tracho-
matis is frequently asymptomatic.
16 Therefore, to
prevent significant infection, the physician must be
able to recognize early asymptomatic infection.
Infection of the fallopian tubes is thought to
occur by progressive upward migration from the
endocervix along the columnar epithelium lining
the endocervix and endometrium. Patients who de-
velop endometritis may not have overt signs or
symptoms of infection. The patient may develop
vague lower abdominal cramping-like pain, recent
onset of dyspareunia or dysmenorrhea, break-
through bleeding if she is utilizing oral contracep-
tive pills (OCPs) for birth control, or irregular
bleeding if she is not using hormonal contracep-
tion.
17 Thus, the patient who is suspected ofhaving
endometritis should be thoroughly evaluated. Spec-
imens for culture of N. gonorrhoeae and C. tra-
chomatis should be obtained from the endocervix.
Then, the portio of the cervix should be thoroughly
cleansed. If Betadine is used, the cervix should be
gently wiped off before an endometrial sample is
taken. The endometrial sample is best obtained by
inserting a pipette through the endocervical canal to
the uterine fundus and obtaining a tissue specimen.
The pipette should be carefully withdrawn without
touching the vaginal walls. The specimen should be
divided into two portions. One should be sent for
histologic evaluation and the other one sent in an
anaerobic transport vessel for the culture of N.
gonorrhoeae, C. trachomatis, aerobic, facultative,
and obligate anaerobic bacteria. The presence of
plasma cells, especially if C. trachomatis is the in-
fecting organism, is highly correlated with salpin-
gitis.
18,19 Endometritis, frequently asymptomatic,
has been reported to occur in approximately 40% of
women with cervicitis.
18 It has also been reported
that women clinically diagnosed as having salpingi-
tis, but laparoscopically found to have normal fallo-
pian tubes, had endometritis by biopsy.
2
RISK FACTORS
The first line of intervention is prevention; how-
ever, the physician rarely has the opportunity to
teach prevention. Therefore, the existence of infec-
tion of the cervix or endometrium should be con-
sidered as the second line of intervention. The sec-
ond opportunity to prevent serious tubal damage
requires recognizing the patient at risk. The physi-
cian must be comfortable with taking a detailed
sexual history from a young patient who is sexually
active, especially one utilizing OCPs, Norplant
(Wyeth-Ayerst Laboratories, P.O. Box 8299, Phil-
adelphia, PA 19101), or other methods of birth
control. The age of first sexual intercourse is a risk
factor. Young, sexually experienced teenagers are
three times more likely to have had PID.
21 The
reason for this risk factor is not understood, but
may be related to the fact that the younger patient is
more likely to have multiple sexual partners, expo-
sure to a larger pool of STDs, and larger areas of
exposed endocervical epithelium. 22’23 Thus, it is
extremely important to obtain an accurate and de-
tailed sexual history from the patient, ideally when
the patient is seen at the initial visit. If the patient
states that she is not sexually active at the present
time, the physician has an excellent opportunity to
begin the educational process on transmission of
STDs and the consequences of infection.
Patients older than 25 years who acquire a C.
trachomatis or N. gonorrhoeae infection that leads to
PID have a greater chance of resulting infertility
than patients younger than 25 years.
24 However,
the younger patient is more likely to experience
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repeated infection and episodes ofPID. The patient
who develops PID is at risk for tubal damage,
depending upon the severity or degree of inflam-
mation she experiences. Women with mild disease
are unlikely to develop tubal damage, whereas
women with severe disease are five times more
likely to develop significant tubal damage.
25
Once the patient has been given the facts con-
cerning the transmission and consequences of
STDs, the discussion should turn to contraceptive
methods. Contraception should also be discussed
with the patient, especially if sexual intercourse is
occurring or is about to commence. Most individ-
uals will have some knowledge of OCPs and per-
haps Norplant. However, they will not be know-
ledgeable about the relationship of hormonal
contraception and the acquisition of STDs. A look
at the available data indicates that the use of oral
contraceptives is associated with increased detection
of cervical infection by C. trachomatis. However,
oral contraceptives appear to be associated with a
decreased risk of PID.
26-29 Although these find-
ings are difficult to reconcile, they may be attribut-
able to behavioral characteristics among individu-
als who use OCPs or to mild, undetected forms of
PID among OCP users. There is also evidence that
estrogen facilitates the adherence of C. trachomatis
to endometrial cells. However, when estrogen is
combined with high doses of progesterone, adher-
ence is not favored.
3 Animal studies have not
helped to clarify this issue. Oral contraceptives fed
to guinea pigs seem to encourage both lower and
upper genital tract infection by C. trachomatis.
1-34
In one study, the use of high-dose estrogen-contain-
ing pills appeared to be associated with a higher
incidence of PID.s
Barrier contraception, including condoms and
spermicides, offers enhanced protection against tu-
bal infertility secondary to infection. The use of
condoms alone provides only marginal protection.
However, combining spermicides and condoms of-
fers a two-fold increase in protection against tubal
infertility.s This point should be emphasized to
young women who are engaging in sexual inter-
course but do not have reliable partners or whose
partners have multiple partners.
Another risk factor, one which is poorly under-
stood, is the relationship between cigarette smoking
and the risk of tubal infertility. This relationship
appears to be statistically stronger in nulliparous
TABLE I. Microbial flora of the healthy vagina
Lactobacillus
Streptococcus
Staphylococcus
Corynebacterium
Diphtheroides
Enterococcus
Escherichia
Proteus
Klebsiella
Enterobacter
Morganella
Peptostreptococcus
Bacteroides
Fusobacterium
Veillonella
Eubacterium
women and dependent upon the intensity of smok-
ing. It does not appear to be related to behavioral
patterns.
6-8 One hypothesis as to the mechanism
by which smoking may be associated with tubal
infertility is that smoking may interfere with the
host immune response, thereby allowing the infect-
ing organisms to gain entrance to the fallopian
tube.
39 The relationship between exogenous, be-
havioral, and endogenous factors and the risk of
tubal infertility is still unclear and remains to be
unraveled.
MICROBIOLOGY AND INFERTILITY
The preceding discussion has alluded to the more
common STDs and their role in infertility. The
role of abnormal bacteriology of the lower genital
tract has also been mentioned. The normal or
healthy vaginal microflora is dominated by Lacto-
bacillus, but numerous other bacteria make up the
normal flora (Table 1). These bacteria exist in a
dynamic relationship that is commensal, synergis-
tic, and antagonistic. The bacteria also exist in a
dynamic equilibrium with their environment, a
balance that is constantly challenged by external and
internal factors.
The relationship of these bacteria is dependent
upon dominance which, in turn, is determined by
bacterial metabolic products as well as environmen-
tal factors. In the healthy state, commensal bac-
teria, lactobacilli, corynebacteria, and diphtheroids
are present in large numbers, with lactobacilli be-
ing present in concentrations of >10
5 cfu/cc of
vaginal fluid. When the environmental conditions
of the vagina become altered, the characteristics of
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the microbial flora are altered to favor the patho-
genic organisms. This can happen when the pH is
altered by environmental factors or by the intro-
duction of exogenous pathogens. The most com-
mon organisms, e.g., N. gonorrhoeae and C. tra-
chomatis, are introduced through sexual intercourse.
However, other conditions not directly related to
sexual activity may also have a bearing, for exam-
ple, BV in which T. vaginalis and other organisms
make up the microflora.
Bacteria such as G. vaginalis occupy a perplex-
ing position in vaginitis. There is little doubt that
this organism can play a pathogenic role under the
appropriate set of circumstances. While there is
considerable discussion over its role in vaginitis,
there are no data to suggest that it plays a significant
role in PID or infertility. Bacteria such as Myco-
plasma and Ureaplasma occupy a significant contro-
versial role in infertility.
Although the role of Mycoplasma and Urea-
plasma as causative agents in infertility has not been
established, they have been implicated. These bac-
teria have been associated with a variety of obstetri-
cal and gynecologic infections, such as postpartum
endometritis, postpartum bacteremia, post-cesar-
ean abdominal wound infection, and early preg-
nancy loss.
40-44 Mycoplasmal organisms are con-
sistently found in 20% to 40% ofthe healthy vaginal
microbial flora, while colonization of the lower
genital tract is directly related to the age of first
coitus and the number of sexual partners.
4s
Infertility attributed to Mycoplasma is a subject
that has waxed and waned over the years. In a study
published in 197 9, Gnarpe and Friberg divided 55
couples into four groups.
46 Group A consisted of
36 couples with unexplained infertility who had
Mycoplasma colonization rates of 25% and Urea-
plasma colonization rates o 92%. Group B con-
tained 19 couples in which the females all had
antisperm antibodies, 15% had Mycoplasma, and
all had Ureaplasma. Group C was made up of 40
pregnant patients, ofwhom 7.5% had Mycoplasma
and 22.5% had Ureaplasma. Group D consisted of
23 men with pregnant wives, none of whom had
Mycoplasma but 26% of whom had Ureaplasma.
This study suggested that Mycoplasma may play a
role in infertility. Graber and colleagues studied 25
women with unexplained infertilityand found Urea-
plasma in 80% of these women compared to a 36%
colonization rate in 25 fertile controls (p < 0.001).
47
Although this study did show a statistical correla-
tion between Mycoplasma and infertility, a direct
cause-and-effect relationship was not demonstrated.
DeLouvois et al, in 1974, studied 120 infertile
couples and 92 pregnant patients and found no
statistical difference with regard to colonization
rates ofMycoplasma or Ureaplasma.
45
These studies encourage investigators to con-
sider that, if Mycoplasma is involved in infertility,
then treatment directed specifically against these
bacteria should result in improved fertility rates.
Friberg and Gnarpe sampled couples for the pres-
ence ofMycoplasma.
48 Ifthe patients were positive,
they were not treated for three months. If they did
not achieve pregnancy within this time, both were
treated with doxycycline, 100 mg twice daily for 7
to 16 days. They found a 25% pregnancy rate in 16
women having antisperm antibodies and a 29%
pregnancy rate in 3 8 women not having antisperm
antibodies. Although this study suggested that there
may be a relationship between colonization and
fertility and that treatment may be of" benefit, there
was no control group. Stray-Pedersen et al, in 197 8,
studied three groups of women.
49 Group A was
made up of 46 women with a history of habitual
abortion, 13 of whom were positive for Urea-
plasma. All were treated with doxycycline and 13
who had positive cultures became pregnant and 10
delivered term infants. Group B consisted of 18
women with unexplained infertility, 50% ofwhom
were colonized with Ureaplasma. Group C con-
tained 45 fertile women, of whom only 7% were
found to be colonized. In 1983, Toth et al reported
on 161 infertile couples in whom only the males
were found to be colonized with Ureaplasma.s
They were treated with doxycycline, 100 mg twice
daily for 28 days. Follow-up cultures showed that
the organism had been eradicated in 129 patients.
Sixty percent of the couples who were culture-neg-
ative achieved pregnancy, whereas only 5% of the
couples in whom the male remained positive
achieved pregnancy.
Several investigators have been unable to con-
firm the relationship of treating Mycoplasma and
Ureaplasma colonization and achieving fertility. In
1975, Harrison et al. studied 88 couples and di-
vided them into three groups, s Group A contained
3 0 couples with colonization rates of23% for Myco-
plasma and 70% for Ureaplasma. Group B con-
tained 28 couples, ofwhom 14% were positive for
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Mycoplasma and 64% for Ureaplasma. Group C
consisted of 30 couples, ofwhom 26% were found
to have Mycoplasma and 57% had Ureaplasma. Pa-
tients in group A were treated with doxycycline for
28 days and 16% achieved pregnancy. Individuals
assigned to group B received a placebo, and 14%
became pregnant. Group C received no treatment,
neither doxycycline nor placebo, and 16% achieved
pregnancy. Idriss et al, in 1978, studied 200 infer-
tile couples and found that 42% of the treatment
group became pregnant, whereas 37% of the non-
52 treatment group became pregnant.
Thus, the data regarding Mycoplasma and Urea-
plasma are at best confusing. The studies that have
been conducted lack a precise scientific approach.
Perhaps studies should be carried out using quanti-
tative bacteriology, serology, and DNA probes of
the tissue in question. A patient with unexplained
infertility is particularly perplexing because an ex-
planation cannot be offered to her, creating a deeper
sense of frustration in the patient. However, the
development ofnew technology in the area of infec-
tious disease is providing a better understanding of
the subtleties of subclinical infection, which should
permit a more scientific approach to studying the
pathophysiology of tubal disease secondary to infec-
tion. This knowledge, in turn, will allow the clini-
cian to prescribe a directed plan of management.
The most important aspect of preventing infer-
tility or tubal damage secondary to infection is not
the design of more potent treatment agents, but the
prevention and recognition of the earliest signs of
infection. Prevention of tubal damage and infertil-
ity does not begin with the treatment of salpingitis.
Rather, the physician must begin the educational
process on the patient’s first visit. Dialogue should
begin at this point and continue with each visit to
reinforce what has been presented at earlier visits
and keep the patient current on the latest informa-
tion regarding transmission and protective mea-
sures. The second opportunity to prevent tubal dam-
age and infertility is the recognition of the early
signs of infection in the asymptomatic patient. These
signs should be used to develop a significant history
and to determine at what degree of risk the particu-
lar patient has placed herself.
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